To estimate distribution's parameters of 18F-Flutemetamol (Vizamyl®) fixation on myocardium for patients with amyloid cardiac injuries.
Hypothesis had been performed that PET with 18F-Flutemetamol (Vizamyl®) could lead an early diagnostic. Indeed, this tracer had been recently used to highlight inter-cerebral beta-amyloid plaques on patients with Alzheimer Disease. Because this labelling is performed on amyloid deposits, this tracer would lead to view and to quantify amyloid deposits within cardiac amyloid injuries. Results of this PET will be combined with scan examinations for a better anatomic tracking.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
7
PET with 18 F-Flutemetamol (Vizamyl ®)
University Hospital Toulouse
Toulouse, France
ratio Heart/ Upper Mediastinum
peak of 18F-Flutemetamol capture
Time frame: average of last 15 minutes
standardized uptake value (SUV) measures
standardized uptake value (SUV) measures
Time frame: average of last 15 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.